Compounds > monocrotaline

monocrotaline and Angiogenesis, Pathologic

monocrotaline has been researched along with Angiogenesis, Pathologic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartelds, B; Berger, RMF; Boersma, B; Dickinson, MG; Mohaupt, S; Takens, J; van Albada, M; van Loon, RLE; Wijnberg, H1
Berger, RM; du Marchie Sarvaas, GJ; Houwertjes, MC; Koster, J; Schoemaker, RG; van Albada, ME1
Hill, NS; Klinger, JR; Pietras, L; Warburton, RR1
Benson, GV; Berry, GJ; Faul, JL; Kao, PN; Nishimura, T; Pearl, RG1
Schraufnagel, DE1

Other Studies

5 other study(ies) available for monocrotaline and Angiogenesis, Pathologic

ArticleYear
Mast cell inhibition improves pulmonary vascular remodeling in pulmonary hypertension.
    Chest, 2012, Volume: 141, Issue:3

    Topics: Animals; Cell Proliferation; Chymases; Cromolyn Sodium; Disease Models, Animal; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Lung; Male; Mast Cells; Monocrotaline; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Rats; Rats, Wistar; Sulfonamides; Thiophenes

2012
Effects of erythropoietin on advanced pulmonary vascular remodelling.
    The European respiratory journal, 2008, Volume: 31, Issue:1

    Topics: Animals; Erythropoietin; Gene Expression Regulation; Heart Ventricles; Hypertension, Pulmonary; Male; Monocrotaline; Neovascularization, Pathologic; Pulmonary Circulation; Rats; Rats, Wistar; Stem Cells; Time Factors; Vascular Endothelial Growth Factor A; Ventricular Remodeling

2008
Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
    Journal of applied physiology (Bethesda, Md. : 1985), 1997, Volume: 83, Issue:4

    Topics: Animals; Antihypertensive Agents; Bosentan; Cardiac Output; Endothelin Receptor Antagonists; Endothelin-1; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; Monocrotaline; Neovascularization, Pathologic; Organ Size; Poisons; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Sulfonamides

1997
Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats.
    American journal of respiratory and critical care medicine, 2000, Volume: 162, Issue:6

    Topics: Analysis of Variance; Animals; Disease Models, Animal; Diterpenes; Drug Evaluation, Preclinical; Epoxy Compounds; Hemodynamics; Hypertension, Pulmonary; Immunosuppressive Agents; Male; Monocrotaline; Neovascularization, Pathologic; Phenanthrenes; Pneumonectomy; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Time Factors; Tunica Intima

2000
Monocrotaline-induced angiogenesis. Differences in the bronchial and pulmonary vasculature.
    The American journal of pathology, 1990, Volume: 137, Issue:5

    Topics: Animals; Capillaries; Female; Hypertrophy; Lung; Microcirculation; Microscopy, Electron, Scanning; Monocrotaline; Neovascularization, Pathologic; Plants, Toxic; Pulmonary Artery; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Senecio

1990